Safety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal Spray

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This study is being conducted to assess the safety, tolerability, and immunogenicity of the live-attenuated CodaVax-H1N1 influenza vaccine as compared to normal saline placebo both administered via intranasal spray to healthy adults.
Epistemonikos ID: e6f909b1e277fbd67828c7e249a48534220419fc
First added on: May 06, 2024